Join the co-founders of Exit 73 Studios as they share their indie game dev journey, from no prior gaming experience to creating the unique game #Blud. Discover the challenges of entering the gaming industry, the strategic decision to share their work on social media, and the advantage of #Blud looking like a TV show. Explore the transition from animation to game development, managing massive amounts of animation assets, and refining game elements based on player feedback.

Dr. Géraldine Androdias reveals how immune checkpoint inhibitors affect multiple sclerosis, highlighting a low risk of relapse in MS patients undergoing cancer treatments. Dr. Bob Fox dives into the significance of neurofilament light chain as a biomarker for disease progression, stressing the need for more research. Dr. Ellen Iacobaeus discusses the unique clinical traits of late-onset MS, advocating for personalized therapy approaches. Additionally, insights on family planning for MS patients underscore the importance of supportive discussions between patients and healthcare providers.

Dr. Justin Abbatemarco and Dr. Bob Fox discuss serum neurofilament light chain as a marker for MS disease activity. They explore the challenges of interpreting these levels against normal protein turnover.